| Market Cap | ₹161Cr |
| ROE | 10.18% |
| P/E Ratio(TTM) | 8.63 |
| EPS(TTM) | 8.87 |
| P/B Ratio | 0.88 |
| Dividend Yield | 0.00% |
| Industry P/E | 33.18 |
| Book Value | 87.12 |
| Debt to Equity | 0.00 |
| Face Value | 10 |
| Parent Organisation | Alpa Laboratories |
| Managing Director | Shri Paresh Chawla |
| Founded | 1988 |
| NSE Symbol | ALPA |
| COMPANY | 52 WEEK | MARKET PRICE | P/E Ratio | |
|---|---|---|---|---|
| JB Chemicals & Pharmaceuticals | NA (0.00%) | 38.94 | ||
| Emcure Pharmaceuticals | NA (0.00%) | 32.07 | ||
| Wockhardt | NA (0.00%) | -439.39 | ||
| Cohance Lifesciences | NA (0.00%) | 64.75 |